Ocugen Inc Ocugen (NASDAQ: OCGN) Announces Partner’s Vaccine Shows 93.4% Efficacy Against COVID19 Ocugen, Inc. (NASDAQ: OCGN) disclosed that its partner Bharat Biotech has revealed the results of its Phase 3 study of COVAXIN.
